In a significant leap forward for neurocritical care, the US Food and Drug Administration (FDA) has granted...
Treatment Innovations
The landscape of multiple sclerosis (MS) care is undergoing a seismic shift. For decades, clinicians have relied...
Executive Summary: The Disconnect Between Discovery and Delivery At HLTH Europe 2026, held in Amsterdam from 15–18...
The pharmaceutical landscape underwent significant shifts this week, highlighted by a major acquisition in the hemato-oncology space,...
In a landmark development for global pharmaceutical markets, Canada has officially become the first G7 nation to...
In a landmark decision for cardiovascular medicine, Artivion has secured premarket approval (PMA) from the U.S. Food...
By Delilah Alvarado Published June 30, 2026 The landscape for the treatment of thyroid eye disease (TED)...
In the high-stakes world of biopharmaceutical manufacturing, the term "technology transfer" is often treated as a clinical,...
In an era where healthcare systems are balancing the dual pressures of rapid technological advancement and fiscal...
In less than a decade, the pharmaceutical landscape has been irrevocably altered by the emergence of glucagon-like...
